Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAI”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableStudy completedNCT03139162
What this trial is testing

Development of Clinical Indicators From the Swiss RAI-HC

Who this might be right for
Frail Elderly Syndrome
School of Health Sciences Geneva 10,000
Not applicableLooking for participantsNCT05024929
What this trial is testing

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Who this might be right for
Papillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02152995
What this trial is testing

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+9 more
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT02695836
What this trial is testing

Improving Nursing Home Care Through Feedback On PerfoRMance Data

Who this might be right for
Organizational Context
University of Alberta 119
Not applicableStudy completedNCT00970359
What this trial is testing

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableStudy completedNCT02084108
What this trial is testing

Efficacy of Integrated Care to Reduce Hospitalization and Nursing Home Placement in Community Dwelling Frail Elderly

Who this might be right for
Chronic Diseases
University Hospital, Geneva 301
Testing effectiveness (Phase 2)UnknownNCT03244956
What this trial is testing

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer

Who this might be right for
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
Gustave Roussy, Cancer Campus, Grand Paris 40
Not applicableStudy completedNCT04009863
What this trial is testing

HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic MNG

Who this might be right for
Non Toxic Multinodular GoiterHigh Intensity Focused UltrasoundRAI
The University of Hong Kong 156
Testing effectiveness (Phase 2)Study completedNCT00098813
What this trial is testing

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Looking for participantsNCT04290663
What this trial is testing

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Who this might be right for
Thyroid CancerIntermediate Risk
Centre Francois Baclesse 476
Large-scale testing (Phase 3)Study completedNCT01876784
What this trial is testing

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 238
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Not applicableUnknownNCT04663451
What this trial is testing

An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.

Who this might be right for
Nodule Solitary ThyroidToxic Multinodular GoiterRadioactive Iodine-Induced Hypothyroidism
Universitair Ziekenhuis Brussel 150
Testing effectiveness (Phase 2)Looking for participantsNCT06007924
What this trial is testing

Avutometinib and Defactinib in People With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 30
Not applicableUnknownNCT06028282
What this trial is testing

Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing

Who this might be right for
Thyroid Disease
State University of New York - Upstate Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06458036
What this trial is testing

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)Looking for participantsNCT03099356
What this trial is testing

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

Who this might be right for
Metastatic Thyroid Cancer
University of Michigan Rogel Cancer Center 22
Early research (Phase 1)Study completedNCT00446979
What this trial is testing

Safety Study of UC-781 Vaginal Microbicide

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 90
Early research (Phase 1)Study completedNCT02456701
What this trial is testing

Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379

Who this might be right for
Thyroid Cancer
Celldex Therapeutics 7
Testing effectiveness (Phase 2)Study completedNCT00563290
What this trial is testing

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Who this might be right for
Recurrent Skin CancerSquamous Cell Carcinoma of the SkinStage 0 Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 7
Load More Results